Indeed, analysis of monocyte subsets in CSF and PB of PRES patients revealed a population of intermediate monocytes expressing high levels of CD14 (CD14++) and low levels of CD16 (CD16+) to be more prevalent in the CSF and PB of PRES patients as compared to controls. Here, CD14 is linked to Posterior Leukoencephalopathy Syndrome.